Recently, many kidney damage-associated biomarkers that may be able to predict an AKI episode have been extensively reviewed, including Chitinase 3-like protein 1 (CHI3L1), Neutrophil gelatinase-associated lipocalin (NGAL), Kidney injury molecule-1, Liver fatty acid binding protein (L-FABP), osteopontin, hemojuvelin and interleukins [99,100,101,102,103,104]. This evidence concerns the gene LCN2 and Nephropathy.